Skip to main content

Atopic Dermatitis NEA Approved Features

NEA Approved Features
07/15/2019
Research has barely scratched the surface of what we can learn about the relationships between immunity and inflammatory skin disease. A leading expert discusses the implications of emerging and future research on managing AD.
Research has barely scratched the surface of what we can learn about the relationships between immunity and inflammatory skin disease. A leading expert discusses the implications of emerging and future research on managing AD.
Research has barely scratched...
07/15/2019
The Dermatologist
NEA Approved Features
05/24/2019
Eczema disproportionately affects patients with skin of color, who have different presentations and treatment concerns.
Eczema disproportionately affects patients with skin of color, who have different presentations and treatment concerns.
Eczema disproportionately...
05/24/2019
The Dermatologist
Partner Approved
05/01/2019
In an interview with The Dermatologist, Dr Lio spoke about the association between AD and food allergy, the efficacy of elimination diets, and how he discusses diet with patients and caregivers.
In an interview with The Dermatologist, Dr Lio spoke about the association between AD and food allergy, the efficacy of elimination diets, and how he discusses diet with patients and caregivers.
In an interview with The...
05/01/2019
The Dermatologist
NEA Approved Features
12/04/2018
JAK inhibitors appear to be effective for the treatment of AD, and this class of medications will influence the current paradigm of AD management.
JAK inhibitors appear to be effective for the treatment of AD, and this class of medications will influence the current paradigm of AD management.
JAK inhibitors appear to be...
12/04/2018
The Dermatologist
NEA Approved Features
10/31/2018
This article explores the literature on the overall risk of malignancy in AD and the risk associated with use of common topical and immunosuppressive medications, as well as newer therapeutic options.
This article explores the literature on the overall risk of malignancy in AD and the risk associated with use of common topical and immunosuppressive medications, as well as newer therapeutic options.
This article explores the...
10/31/2018
The Dermatologist
NEA Approved Features
10/21/2018
This article discusses the role of self-management in the treatment of atopic dermatitis, a promising strategy that combines patient education and psychological support to actively engage patients in their health care.
This article discusses the role of self-management in the treatment of atopic dermatitis, a promising strategy that combines patient education and psychological support to actively engage patients in their health care.
This article discusses the role...
10/21/2018
The Dermatologist
NEA Approved Features
09/11/2018
Vivian Shi, MD, and Aleksi Hendricks, BS, discuss the diagnosis and treatment of head and neck atopic dermatitis.
Vivian Shi, MD, and Aleksi Hendricks, BS, discuss the diagnosis and treatment of head and neck atopic dermatitis.
Vivian Shi, MD, and Aleksi...
09/11/2018
The Dermatologist
NEA Approved Features
09/09/2018
Jordan Daniel Rosen, BS, and Gil Yosipovitch, MD, briefly review the therapeutic ladder for the treatment of AD itch and provide a few tools of the trade for managing patients with treatment-refractory itch.
Jordan Daniel Rosen, BS, and Gil Yosipovitch, MD, briefly review the therapeutic ladder for the treatment of AD itch and provide a few tools of the trade for managing patients with treatment-refractory itch.
Jordan Daniel Rosen, BS, and Gil...
09/09/2018
The Dermatologist
NEA Approved Features
08/01/2018
In this online exclusive, Tips on Treating Adult Atopic Dermatitis, Aida Lugo-Somolinos, MD, shares her approach for diagnosing and treating AD in adult patients.
In this online exclusive, Tips on Treating Adult Atopic Dermatitis, Aida Lugo-Somolinos, MD, shares her approach for diagnosing and treating AD in adult patients.
In this online exclusive, Tips...
08/01/2018
The Dermatologist
NEA Approved Features
07/09/2018
In part 2, Vivian Shi, MD, discusses which products and ingredients patients should avoid, the Eczema Action Plan, and the top questions she receives most from her patients.
In part 2, Vivian Shi, MD, discusses which products and ingredients patients should avoid, the Eczema Action Plan, and the top questions she receives most from her patients.
In part 2, Vivian Shi, MD,...
07/09/2018
The Dermatologist